About TowerBrook

• Founded: 2005

• Headquarters: New York and London

• AUM: Approximately $20bn as of 2024

• Strategy: Mid-market buyout, business services, healthcare, and consumer sectors across North America and Europe

• Track record: Fund V closed at $4.5bn in 2021; Fund IV raised $3bn in 2017

• Leadership: Founding partners Neal Moszkowski and Ramez Sousou

The raise marks the first close of TowerBrook's sixth flagship fund in what the source describes as a challenging environment for buyout fundraising. The firm has not disclosed a target size for the vehicle. Fund V, which closed three years ago at $4.5bn, deployed capital across both continents into sectors including education services and specialty healthcare, suggesting the new fund will likely maintain a similar cross-border scope.

The $2.7bn first close positions TowerBrook's Fund VI roughly 40% below its predecessor's final size at a comparable stage, reflecting the tighter fundraising conditions that have persisted since late 2022. Several mid-market buyout managers that closed funds in the $3bn–$5bn range during 2020–2021 have reported extended fundraising timelines for successor vehicles — Advent International's GPE X took 18 months to reach final close at $25bn in early 2024, while EQT's mid-market fund closed at €6.4bn in late 2023 after a year-long process. TowerBrook's prior fund reached final close within nine months of launch.

The question is whether Fund VI scales to match or exceed Fund V's $4.5bn, or whether the firm opts for a right-sized vehicle that reflects current deployment realities. Mid-market buyout funds that closed in 2021–2022 have faced slower exit markets and compressed deployment windows, making vintage discipline more critical. If TowerBrook can demonstrate differentiated deal flow in its core sectors — particularly healthcare, where regulatory tailwinds remain supportive — a Fund V-plus outcome is plausible by final close.

Source: Private Equity Wire